These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24801771)

  • 1. Different biomarkers in non-small cell lung cancer in blood vessel invasion.
    Zhang C; Liu Y; Guo S; Zhang J
    Cell Biochem Biophys; 2014 Nov; 70(2):777-84. PubMed ID: 24801771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes.
    Maeda R; Ishii G; Ito M; Hishida T; Yoshida J; Nishimura M; Haga H; Nagai K; Ochiai A
    J Thorac Oncol; 2012 Mar; 7(3):503-11. PubMed ID: 22198428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
    Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
    Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of maspin in non-small-cell lung cancer: correlation with clinical features.
    Takanami I; Abiko T; Koizumi S
    Clin Lung Cancer; 2008 Nov; 9(6):361-6. PubMed ID: 19073519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I
    Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
    Koukourakis MI; Giatromanolaki A; Brekken RA; Sivridis E; Gatter KC; Harris AL; Sage EH
    Cancer Res; 2003 Sep; 63(17):5376-80. PubMed ID: 14500371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.
    Usui S; Minami Y; Shiozawa T; Iyama S; Satomi K; Sakashita S; Sato Y; Noguchi M
    Lung Cancer; 2013 Dec; 82(3):407-12. PubMed ID: 24094286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor expression and neovascularization in non--small cell lung carcinoma.
    Ozbudak IH; Ozbilim G; Kucukosmanoglu I; Dertsiz L; Demircan A
    Int J Surg Pathol; 2009 Oct; 17(5):390-5. PubMed ID: 18849317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of angiopoietins and its clinical significance in non-small cell lung cancer.
    Tanaka F; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H
    Cancer Res; 2002 Dec; 62(23):7124-9. PubMed ID: 12460935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3.
    Zhao B; Han H; Chen J; Zhang Z; Li S; Fang F; Zheng Q; Ma Y; Zhang J; Wu N; Yang Y
    Cancer Lett; 2014 Jan; 342(1):43-51. PubMed ID: 23981581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSPA2 is expressed in human tumors and correlates with clinical features in non-small cell lung carcinoma patients.
    Scieglinska D; Gogler-Piglowska A; Butkiewicz D; Chekan M; Malusecka E; Harasim J; Habryka A; Krawczyk Z
    Anticancer Res; 2014 Jun; 34(6):2833-40. PubMed ID: 24922646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer.
    Yuan A; Yang PC; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1957-63. PubMed ID: 11069840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
    Miyoshi K; Moriyama S; Kunitomo T; Nawa S
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer.
    Shoji F; Haro A; Yoshida T; Ito K; Morodomi Y; Yano T; Maehara Y
    Ann Thorac Surg; 2010 Mar; 89(3):864-9. PubMed ID: 20172144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased NDRG1 expression is associated with advanced T stages and poor vascularization in non-small cell lung cancer.
    Fan C; Yu J; Liu Y; Xu H; Wang E
    Pathol Oncol Res; 2012 Jul; 18(3):549-56. PubMed ID: 20853080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated macrophages: the double-edged sword in cancer progression.
    Chen JJ; Lin YC; Yao PL; Yuan A; Chen HY; Shun CT; Tsai MF; Chen CH; Yang PC
    J Clin Oncol; 2005 Feb; 23(5):953-64. PubMed ID: 15598976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.